q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

March 2020 Medicare Drug List Updates: Sixty-eight (68) medications added to 2020 Medicare Part D Drug plan formularies.

Category: Monthly Formulary Changes
Published: Apr, 05 2020 02:04:52
< Previous
Next >
We now have the recently released March 2020 Medicare Part D prescription drug plan formulary (drug lists) data online and included in our Formulary Browser and Drug Finder.  The March formulary updates include the addition of 99 new National Drug Codes (NDCs), representing 68 different prescription drugs, many with multiple strengths.  The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).

Highlights of the March 2020 Formulary update include twenty-five (25) newly-added generic drugs:   The March Medicare Part D drug data includes 25 generic medications, 13 of which are newly-introduced generic drugs.  These drugs include:
  • BLISOVI 24 FE [TARINA FE 1/20®],
  • BLISOVI FE 1.5-30 [MICROGESTIN FE 1.5/30®],
  • CIPROFLOX-FLUOCINLN,
  • DEFERASIROX [JADENU®],
  • IVERMECTIN CREAM [SOOLANTRA®],
  • LEVONOR-ETH ESTRAD [VIENVA®],
  • METOPROLOL [TOPROL XL®],
  • POSACONAZOLE [NOXAFIL®],
  • PRETOMANID,
  • TIADYLT ER [TIAZAC®],
  • TOVET EMOLLIENT [OLUX-E®],
  • ZALEPLON [SONATA®], and
  • STAVUDINE [ZERIT®].

You can see our article "March 2020 Drug List Updates: Twenty-five (25) new generic drugs added to many Medicare Part D plan formularies" found at https://Q1News.com/819.html for more about coverage the new generics.


The March 2020 Formulary update includes fourty-three (43) newly-added brand-name drugs:  The March drug data updates also include 43 new brand-name drugs, 21 of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • AKLIEF®,
  • ANNOVERA®,
  • BALCOLTRA®,
  • CEQUA®,
  • DRIZALMA®,
  • DUAKLIR PRESSAIR®,
  • GVOKE®,
  • KATERZIA®,
  • NAYZILAM®,
  • NOURIANZ®,
  • OLUMIANT®,
  • QBREXZA®,
  • ROZLYTREK®,
  • SITAVIG®,
  • SLYND®,
  • TOSYMRA®,
  • TRIKAFTA®,
  • VYNDAMAX®,
  • WAKIX®,
  • XENLETA®, and
  • ZIEXTENZO®.

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.

Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans ( PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Reminder: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 99 new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 2
New Drug 34
New Drug and Strength 36
New Drug, Manufacturer and Strength 2
New Manufacturer 1
New Manufacturer and Strength 6
New Manufacturer, Strength and Delivery Form 4
New Strength 14
Total New NDCs 99

The following chart details the 99 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
53746067001ACEBUTOLOL 400 MG CAPSULE [Sectral]56373New Manufacturer and Strength
00299593545AKLIEF 0.005% CREAM (G)02New Drug
00781106105ALPRAZOLAM 0.25 MG TABLET [Xanax]64372New Drug
13668031190AMLODIPINE-OLMESARTAN 10-40 MG TABLET [AZOR]24289New Strength
27241008303AMLODIPINE-OLMESARTAN 5-20 MG Tablet [AZOR]24289New Strength
50261031301ANNOVERA VAGINAL RING012New Drug
75854060228BALCOLTRA TABLET010New Drug
68180086473BLISOVI 24 FE TABLET [Tarina Fe 1/20]36269New Drug and Strength
68180086673BLISOVI FE 1.5-30 TABLET [Microgestin Fe 1.5/30]60345New Drug and Strength
47335050696CEQUA 0.09% SOLUTION DROPERETTE07New Drug
52536008014CIPROFLOX-FLUOCINLN 0.3-0.025% VIAL445New Drug
25021011502CLINDAMYCIN PH 300 MG/2 ML VIAL [Cleocin]65369New Drug and Strength
25021011504CLINDAMYCIN PH 600 MG/4 ML VIAL [Cleocin]65378New Drug and Strength
66993094748CLOCORTOLONE PIVALATE 0.1% CREAM (g) [Cloderm]488New Drug
71403080445CLODERM 0.1% CREAM (g)019New Drug
62332041230DEFERASIROX 360 MG TABLET [Jadenu]49317New Drug and Strength
62332041030DEFERASIROX 90 MG TABLET [Jadenu]49317New Drug and Strength
63323082475DEXTROSE 10%-WATER IV SOLUTION DEHP FR BG67386New Manufacturer
16714059101DIGOXIN 0.25 MG TABLET [Lanoxin]67386New Manufacturer and Strength
66689032702DIGOXIN 0.05 MG/ML SOLUTION [Lanoxin]67373New Manufacturer and Strength
47335061630DRIZALMA SPRINKLE DR 20 MG CAPSULE37191New Drug and Strength
47335061730DRIZALMA SPRINKLE DR 30 MG CAPSULE37188New Drug and Strength
47335061830DRIZALMA SPRINKLE DR 40 MG CAPSULE37191New Drug and Strength
47335061930DRIZALMA SPRINKLE DR 60 MG CAPSULE37191New Drug and Strength
72124000101DUAKLIR PRESSAIR 400-12MCG INH AER POW BA26New Drug
00310183030FASENRA PEN 30 MG/ML AUTO INJCT5165New Delivery Form
52609000705FERRIPROX 1,000 MG TABLET19244New Strength
00169320515FIASP PENFILL 100 UNIT/ML CART CARTRIDGE9155New Delivery Form
23155047344FUROSEMIDE 100 MG/10 ML VIAL66387New Manufacturer and Strength
00049005260GEODON 20 MG CAPSULE37New Strength
00049005660GEODON 60 MG CAPSULE37New Strength
00049005860GEODON 80 MG CAPSULE37New Strength
72065013012GVOKE 0.5 MG/0.1 ML SYRINGE13138New Drug and Strength
72065013112GVOKE 1 MG/0.2 ML SYRINGE13141New Drug and Strength
00591405289IVERMECTIN 1% CREAM (g) [Soolantra]256New Drug
42515000201IXIARO 6 UNIT(6 MCG)/0.5ML SYRINGE67388New Drug
00074327813K-TAB ER 10 MEQ TABLET [Klotrix]536New Drug
52652500101KATERZIA 1 MG/ML ORAL SUSPENSION346New Drug
00338081104KCL 20 MEQ IN D5W-LACT RINGER IV SOLUTION37242New Strength
43538053010KETODAN 2% FOAM6102New Drug
00378728753LEVONOR-ETH ESTRAD 0.1-0.02 MG Tablet [Vienva]65364New Drug
00093323001METHYLPHENIDATE LA 20 MG CAPSULE CPBP 50-50 [Ritalin LA]9186New Drug and Strength
00093323101METHYLPHENIDATE LA 30 MG CAPSULE CPBP 50-50 [Ritalin LA]9185New Drug and Strength
51862061430METHYLPHENIDATE LA 60 MG CAPSULE CPBP 50-50 [Ritalin LA]8154New Drug and Strength
16714085501METOPROLOL SUCC ER 200 MG TABLET 24H [Toprol XL]67388New Drug, Manufacturer and Strength
00378459510METOPROLOL SUCC ER 25 MG TABLET 24H [Toprol XL]67388New Drug, Manufacturer and Strength
52817035810METOPROLOL TARTRATE 37.5 MG TABLET26126New Manufacturer and Strength
52817035910METOPROLOL TARTRATE 75 MG TABLET26128New Manufacturer and Strength
00713016612MIGERGOT 2-100 MG SUPPOSITORY SUPP.RECT31160New Drug
00832027311MORPHINE SULFATE IR 15 MG TABLET [MSIR]67388New Manufacturer, Strength and Delivery Form
00832027411MORPHINE SULFATE IR 30 MG TABLET [MSIR]67388New Manufacturer, Strength and Delivery Form
50474050015NAYZILAM 5 MG NASAL SPRAY65381New Drug
42747060290NOURIANZ 20 MG TABLET124New Drug and Strength
42747060490NOURIANZ 40 MG TABLET124New Drug and Strength
24510017460NUCYNTA ER 150 MG TABLET ER 12H26196New Strength
24510023260NUCYNTA ER 200 MG TABLET ER 12H26196New Strength
24510029160NUCYNTA ER 250 MG TABLET ER 12H26195New Strength
00002473230OLUMIANT 1 MG TABLET3124New Strength
00069101101PANZYGA 10% (1 G/10 ML) VIAL25167New Drug and Strength
00069131201PANZYGA 10% (10 G/100 ML) VIAL25167New Drug and Strength
00069110901PANZYGA 10% (2.5 G/25 ML) VIAL25167New Drug and Strength
00069141501PANZYGA 10% (20G/200ML) VIAL25167New Drug and Strength
00069155801PANZYGA 10% (30 G/300 ML) VIAL25167New Drug and Strength
00069122401PANZYGA 10% (5 G/50 ML) VIAL25167New Drug and Strength
62559056001PINDOLOL 5 MG TABLET [Visken]63362New Drug
68180089373PIRMELLA 1-35 28 TABLET63359New Drug
00527213335POSACONAZOLE DR 100 MG TABLET [Noxafil]59364New Drug
00338070948POTASSIUM CL 10 MEQ/100 ML SOL PIGGYBACK42282New Strength
49502047626PRETOMANID 200 MG TABLET023New Drug
13533070002PROLASTIN C 1,000 MG VIAL63362New Drug
00009006501PROVERA 2.5 MG TABLET37New Strength
61748001201PYRAZINAMIDE 500 MG TABLET67388New Drug
70428001112QBREXZA 2.4% CLOTH TOWELETTE09New Drug
50242009130ROZLYTREK 100 MG CAPSULE67387New Drug and Strength
50242009490ROZLYTREK 200 MG CAPSULE67387New Drug and Strength
71403004902SITAVIG 50 MG BUCCAL TABLET MA06New Drug
00642747001SLYND 4 MG TABLET367New Drug
15054112004SOMATULINE DEPOT 120 MG/0.5 ML SYRINGE67388New Drug and Strength
15054106004SOMATULINE DEPOT 60 MG/0.2 ML SYRINGE67386New Drug and Strength
15054109004SOMATULINE DEPOT 90 MG/0.3 ML SYRINGE67388New Drug and Strength
64980035406STAVUDINE 15 MG CAPSULE [Zerit]67388New Drug and Strength
64980035506STAVUDINE 20 MG CAPSULE [Zerit]67388New Drug and Strength
64980035606STAVUDINE 30 MG CAPSULE [Zerit]67388New Drug and Strength
64980035706STAVUDINE 40 MG CAPSULE [Zerit]67388New Drug and Strength
45802028139TESTOSTERONE 1.62%(1.25 G) GEL PACKET [AndroGel]45258New Strength
68382074916TIADYLT ER 360 MG CAPSULE SA 24H [Tiazac]56343New Drug
67857081261TOSYMRA 10 MG NASAL SPRAY016New Drug
43538095210TOVET EMOLLIENT 0.05% FOAM [Olux-E]788New Drug
51167033101TRIKAFTA 100/50/75 MG-150 MG TABLET SEQ24153New Drug
62559083003VANCOMYCIN 250 MG/5 ML SOLUTION RECON [Vancocin]10110New Manufacturer, Strength and Delivery Form
70720010102VARUBI 90 MG TABLET4136New Drug
50419039201VITRAKVI 20 MG/ML SOLUTION67388New Manufacturer, Strength and Delivery Form
00069873030VYNDAMAX 61 MG CAPSULE37209New Drug
72028017803WAKIX 17.8 MG TABLET124New Drug and Strength
72028004503WAKIX 4.45 MG TABLET124New Drug and Strength
72000011030XENLETA 600 MG TABLET530New Drug
29300013201ZALEPLON 10 MG CAPSULE [Sonata]48325New Drug and Strength
29300013101ZALEPLON 5 MG CAPSULE [Sonata]48325New Drug and Strength
61314086601ZIEXTENZO 6 MG/0.6 ML SYRINGE187New Drug




Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.



Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.